Home › Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy
 

Keywords :   


Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy

2013-04-02 09:55:00| drugdiscoveryonline News Articles

Compugen Ltd. disclosed recently the initiation of its second focused discovery program, aimed at identification of novel targets for antibody-drug conjugate (ADC) cancer therapy focusing on clinical situations with poor survival rates and/or recurrent cancers

Tags: program target cancer focused

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »